We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$2.6B
AUM Growth
+$351M
Cap. Flow
+$870M
Cap. Flow %
33.44%
Top 10 Hldgs %
12.89%
Holding
1,330
New
552
Increased
277
Reduced
191
Closed
296

Sector Composition

Rank Sector Weight
1 Healthcare 19.37%
2 Industrials 14.55%
3 Consumer Discretionary 13.2%
4 Technology 10.71%
5 Financials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
1251
Wells Fargo
WFC
$254B
-186,190
Closed -$9.79M
WLK icon
1252
Westlake Corp
WLK
$10.1B
-26,300
Closed -$2.19M
WM icon
1253
Waste Management
WM
$89.6B
-3,200
Closed -$289K
WOLF icon
1254
Wolfspeed
WOLF
$1.34B
-30,000
Closed -$1.14M
WPC icon
1255
W.P. Carey
WPC
$16.2B
-3,574
Closed -$225K
XLV icon
1256
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
-40,379
Closed -$3.84M
XNCR icon
1257
Xencor
XNCR
$2.07B
-96,900
Closed -$3.78M
XRAY icon
1258
Dentsply Sirona
XRAY
$2.18B
-14,700
Closed -$555K
XYL icon
1259
Xylem
XYL
$26.5B
-5,342
Closed -$427K
YELP icon
1260
Yelp
YELP
$1.27B
-150,900
Closed -$7.42M
NVRO
1261
DELISTED
NEVRO CORP.
NVRO
-6,100
Closed -$348K
GTHX
1262
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-8,205
Closed -$429K
LSXMK
1263
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
-31,117
Closed -$1.03M
LSXMA
1264
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
-30,174
Closed -$947K
MRNS
1265
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-10,025
Closed -$401K
PGTI
1266
DELISTED
PGT, Inc.
PGTI
-103,200
Closed -$2.23M
SPLK
1267
DELISTED
Splunk Inc
SPLK
-2,300
Closed -$278K
SIEN
1268
DELISTED
Sientra, Inc.
SIEN
-31,600
Closed -$7.55M
FTCH
1269
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-30,000
Closed -$817K
APRN
1270
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
-972
Closed -$18K
NEWR
1271
DELISTED
New Relic, Inc.
NEWR
-8,621
Closed -$812K
PRTK
1272
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-85,000
Closed -$825K
DMS
1273
DELISTED
Digital Media Solutions, Inc.
DMS
-33,333
Closed -$4.88M
SPPI
1274
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-14,800
Closed -$249K
AJRD
1275
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-6,600
Closed -$224K

Similar funds

Steve Schonfeld's Q4 2018 Portfolio in Review

As of Q4 2018, Steve Schonfeld held 1,330 positions worth $2.6B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Steve Schonfeld deployed $870M of net new capital in Q4 2018, opening 552 new positions and adding to 277 existing holdings. Its largest new stake was Shire pic: 183,006 shares worth $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Fortive, an estimated $26.5M trimmed.

  • Steve Schonfeld's largest Q4 2018 buy was Shire pic: 183,006 shares worth $31.8M.
  • Steve Schonfeld added most to Plains GP Holdings in Q4 2018, an estimated $26.5M increase.
  • Steve Schonfeld's biggest Q4 2018 reduction was Fortive, cutting an estimated $26.5M.
  • Steve Schonfeld fully exited Churchill Capital Corp in Q4 2018, selling an estimated $20.3M.
  • Steve Schonfeld's ten largest holdings make up 13% of its $2.6B portfolio in Q4 2018.
  • Steve Schonfeld opened 552 new positions and closed 296 in Q4 2018.
  • Steve Schonfeld's portfolio value rose 16% quarter-over-quarter to $2.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.